Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002590417 | SCV002954247 | pathogenic | Jeune thoracic dystrophy | 2024-12-02 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Met3607Valfs*5) in the DYNC2H1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DYNC2H1 are known to be pathogenic (PMID: 23339108, 32753734, 33755199). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with DYNC2H1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1916428). For these reasons, this variant has been classified as Pathogenic. |
Ce |
RCV003886582 | SCV004703546 | pathogenic | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | DYNC2H1: PVS1, PM2 |
Fulgent Genetics, |
RCV005042902 | SCV005680478 | likely pathogenic | Asphyxiating thoracic dystrophy 3 | 2024-03-11 | criteria provided, single submitter | clinical testing |